The Impact of the COVID-19 Pandemic and Lockdown on the Outcome of Glioblastoma
Journal of Neurological Surgery Part A: Central European Neurosurgery · 01.03.2025 · 86 (02) · 120-127
DOI: 10.1055/s-0044-1779262 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neurological Surgery Part A: Central European Neurosurgery, erschienen am 01.03.2025. Verfasst von Daniele Armocida und 9 weiteren Autor:innen. Beteiligte Einrichtung: Neurosurgery Division, Human Neurosciences Department, "Sapienza" University, Rome, Italy. Hauptthemen laut MEDLINE: Glioblastoma, COVID-19, Brain Neoplasms, Quarantine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
Background
Rapid spread of the SARS-CoV-2 pandemic in 2020 led to an indirect effect on non-COVID patients. Since neuro-oncology cases are unique and brain tumors need a specific therapeutic protocol at proper doses and at the right times, the effects of the pandemic on health care services for patients with glioblastomas (GBs) and their impact on overall survival (OS) and quality of life are not yet known.
Methods
We conducted a retrospective study of 142 GB patients who underwent surgery, radiation, and chemotherapy before and after the lockdown period, aiming to determine the differences in access to care, treatment modality, and adjuvant therapies, and how the lockdown changed the prognosis.
Results
The number of procedures performed for GB during the pandemic was comparable to that of the prepandemic period, and patients received standard care. There was a significant difference in the volume of lesions measured at diagnosis with a decreased number of “accidental” diagnoses and expression of a reduced use by the patient for a checkup or follow-up examinations. Patients expressed a significantly lower performance index in the lockdown period with longer progression-free survival (PFS) in the face of a comparable mean time to OS.
Conclusion
Patients treated surgically for GB during the pandemic period had a more pronounced and earlier reduction in performance status than patients treated during the same period the year before. This appears to be primarily due to lower levels of care in the rehabilitation centers and more frequent discontinuation of adjuvant care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Neurosurgery Division, Human Neurosciences Department, "Sapienza" University, Rome, Italy.
- IRCCS "Neuromed" Pozzilli (IS), Italy.
- Department of Radiotherapy, Policlinico Umberto I "Sapienza" University of Rome, Rome, Italy.
- Unit of Neurosurgery, AOU Città della Salute e della Scienza, Torino, Italy.
ORCID-Profile: Daniele Armocida
Zitieren
APA
Armocida, D., D'Angelo, L., Pietro, R., Chiarello, G., Jiang, T., Rizzo, F., Garbossa, D., Frati, A., Marampon, F., & Santoro, A. (2025). The Impact of the COVID-19 Pandemic and Lockdown on the Outcome of Glioblastoma. Journal of Neurological Surgery Part A: Central European Neurosurgery, 86(02), 120-127. https://doi.org/10.1055/s-0044-1779262
Vancouver
Armocida D, D'Angelo L, Pietro R, Chiarello G, Jiang T, Rizzo F, et al. The Impact of the COVID-19 Pandemic and Lockdown on the Outcome of Glioblastoma. Journal of Neurological Surgery Part A: Central European Neurosurgery. 2025;86(02):120-127. doi:10.1055/s-0044-1779262
BibTeX
@article{Armocida2025,
author = {Armocida, Daniele and D'Angelo, Luca and Pietro, Raffaella De and Chiarello, Giuseppina and Jiang, Tingting and Rizzo, Francesca and Garbossa, Diego and Frati, Alessandro and Marampon, Francesco and Santoro, Antonio},
title = {The Impact of the COVID-19 Pandemic and Lockdown on the Outcome of Glioblastoma},
journal = {Journal of Neurological Surgery Part A: Central European Neurosurgery},
year = {2025},
volume = {86},
number = {02},
pages = {120--127},
doi = {10.1055/s-0044-1779262}
}
EUVIMED